FindTrial
Sign In

Effect of atomised Dexmedetomidine on post operative sore throat

Evaluation of efficacy of atomisation of different doses of Dexmedetomidine used during endotracheal Intubation to prevent Postoperative Sore Throat in tympanomastoidectomy surgeries - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068726
Enrollment
90
Registered
2024-06-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: nil: nil Intervention2: Group A: Dexmedetomidine 0.5mcg/kg Intervention3: Group B: Dexmedetomidine 0.75mcg/kg Intervention4: Group C: Dexmedetomidine 1mcg/kg Control Intervention1: nil:

Sponsors

Vinayak Saran
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA 1 and 2 patients 2. Posted for elective tympanomastoidectomy surgical procedures requiring general anaesthesia with endotracheal intubation

Exclusion criteria

Exclusion criteria: 1. Patients with active Upper Respiratory Tract Infection (URTI) 2. Surgical procedures lasting for more than 180 minutes. 3. Mallampatti Grade (MPG) III and IV 4. Anticipated difficult intubation 5. More than 1 attempt for endotracheal intubation 6. Obesity (BMI > 30) 7. Gastro-esophageal reflux disease, Pregnancy 8. Patients with significant cardiovascular and respiratory diseases such as asthma, COPD 9. Patients with significant pre-operative derangement of renal/hepatic functions 10. Any allergic reaction to Dexmedetomidine

Design outcomes

Primary

MeasureTime frame
Incidence of post operative sore throat as per Harding and McVey scoreTimepoint: 30 mins 6 hrs 12 hrs 24 hrs—

Secondary

MeasureTime frame
Drug requirement of vecuronium and fentanylTimepoint: intra operative;Sedation scoreTimepoint: 30 mins—

Countries

India

Contacts

Public ContactDr Divya Gupta

Swami Rama Himalayan University

dr_divyagupta@rediffmail.com9456570288

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026